ERCC4 and neoplasm: Intriguingly, the recruitment of downstream effectors of NER to DNA lesion sites, including XPA and XPF, is disrupted, allowing excessive accumulation of the cytotoxic Pt-DNA adducts in cisplatin-resistant tumour cells.